---
figid: PMC10742473__genes-14-02182-g004
figtitle: Canonical and alternative signaling pathways in B-cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10742473
filename: genes-14-02182-g004.jpg
figlink: /pmc/articles/PMC10742473/figure/F4
number: F4
caption: Canonical and alternative signaling pathways in B-cells. The canonical B-cell
  receptor signaling pathway is shown (left) highlighting BTK (blue) and BTK inhibitors
  (BTKi—Orange). BTKi resistance alternative signaling pathways are shown (right)
  highlighting alternative signaling from activating mutations in PLCG2 (green), mutations
  in NFkB (orange), signaling through activation of cell surface receptor CD19 (yellow),
  epigenetic signaling described from RAC2 activation (blue), or proposed noncatalytic
  signaling of kinase dead mutated BTK through HCK activation (purple)
papertitle: 'Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic
  Leukemia (CLL)'
reftext: Alexandra Chirino, et al. Genes (Basel). 2023 Dec;14(12).
year: '2023'
doi: 10.3390/genes14122182
journal_title: Genes
journal_nlm_ta: Genes (Basel)
publisher_name: MDPI
keywords: chronic lymphocytic leukemia | Bruton’s tyrosine kinase | resistance mutations
  | targeted therapy
automl_pathway: 0.9525027
figid_alias: PMC10742473__F4
figtype: Figure
redirect_from: /figures/PMC10742473__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10742473__genes-14-02182-g004.html
  '@type': Dataset
  description: Canonical and alternative signaling pathways in B-cells. The canonical
    B-cell receptor signaling pathway is shown (left) highlighting BTK (blue) and
    BTK inhibitors (BTKi—Orange). BTKi resistance alternative signaling pathways are
    shown (right) highlighting alternative signaling from activating mutations in
    PLCG2 (green), mutations in NFkB (orange), signaling through activation of cell
    surface receptor CD19 (yellow), epigenetic signaling described from RAC2 activation
    (blue), or proposed noncatalytic signaling of kinase dead mutated BTK through
    HCK activation (purple)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - RN7SL263P
  - LYN
  - BLNK
  - SYK
  - IBTK
  - BTK
  - PLCG2
  - CD19
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - HCK
  - VAV1
  - VAV2
  - VAV3
  - AKT1
  - AKT2
  - AKT3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - RAC2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - Ca2+
---
